These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 24624919)

  • 1. An update on the pharmacogenomics of metformin: progress, problems and potential.
    Todd JN; Florez JC
    Pharmacogenomics; 2014 Mar; 15(4):529-39. PubMed ID: 24624919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin pharmacogenomics: current status and future directions.
    Pawlyk AC; Giacomini KM; McKeon C; Shuldiner AR; Florez JC
    Diabetes; 2014 Aug; 63(8):2590-9. PubMed ID: 25060887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin pharmacogenomics: biomarkers to mechanisms.
    Wang L; Weinshilboum R
    Diabetes; 2014 Aug; 63(8):2609-10. PubMed ID: 25060891
    [No Abstract]   [Full Text] [Related]  

  • 4. A Review of the Impact of Pharmacogenetics and Metabolomics on the Efficacy of Metformin in Type 2 Diabetes.
    Damanhouri ZA; Alkreathy HM; Alharbi FA; Abualhamail H; Ahmad MS
    Int J Med Sci; 2023; 20(1):142-150. PubMed ID: 36619226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetics in type 2 diabetes: precision medicine or discovery tool?
    Florez JC
    Diabetologia; 2017 May; 60(5):800-807. PubMed ID: 28283684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetics of oral antidiabetic therapy.
    Ordelheide AM; Hrabě de Angelis M; Häring HU; Staiger H
    Pharmacogenomics; 2018 Apr; 19(6):577-587. PubMed ID: 29580198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin transporter pharmacogenomics: insights into drug disposition-where are we now?
    Chan P; Shao L; Tomlinson B; Zhang Y; Liu ZM
    Expert Opin Drug Metab Toxicol; 2018 Nov; 14(11):1149-1159. PubMed ID: 30375241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current progress in pharmacogenomics of Type 2 diabetes: A systemic overview.
    Guo Z; Priefer R
    Diabetes Metab Syndr; 2021; 15(5):102239. PubMed ID: 34371302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetics: Implications for Modern Type 2 Diabetes Therapy.
    Staiger H; Schaeffeler E; Schwab M; Häring HU
    Rev Diabet Stud; 2015; 12(3-4):363-76. PubMed ID: 27111121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetics of Type 2 Diabetes-Progress and Prospects.
    Nasykhova YA; Tonyan ZN; Mikhailova AA; Danilova MM; Glotov AS
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The study to understand the genetics of the acute response to metformin and glipizide in humans (SUGAR-MGH): design of a pharmacogenetic resource for type 2 diabetes.
    Walford GA; Colomo N; Todd JN; Billings LK; Fernandez M; Chamarthi B; Warner AS; Davis J; Littleton KR; Hernandez AM; Fanelli RR; Lanier A; Barbato C; Ackerman RJ; Khan SQ; Bui R; Garber L; Stolerman ES; Moore AF; Huang C; Kaur V; Harden M; Taylor A; Chen L; Manning AK; Huang P; Wexler D; McCarthy RM; Lo J; Thomas MK; Grant RW; Goldfine A; Hudson MS; Florez JC
    PLoS One; 2015; 10(3):e0121553. PubMed ID: 25812009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacogenetics of metformin.
    Florez JC
    Diabetologia; 2017 Sep; 60(9):1648-1655. PubMed ID: 28770331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin: from mechanisms of action to therapies.
    Foretz M; Guigas B; Bertrand L; Pollak M; Viollet B
    Cell Metab; 2014 Dec; 20(6):953-66. PubMed ID: 25456737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of clinical and pharmacogenetic factors influencing metformin response in Type 2 diabetes mellitus.
    Pérez-Gómez N; Fernández-Ortega MD; Elizari-Roncal M; Santos-Mazo E; la Maza-Pereg L; Calvo S; Alcaraz R; Sanz-Solas A; Vinuesa R; Saiz-Rodríguez M
    Pharmacogenomics; 2023 Aug; 24(12):651-663. PubMed ID: 37610884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetic variation and metformin response.
    Chen S; Zhou J; Xi M; Jia Y; Wong Y; Zhao J; Ding L; Zhang J; Wen A
    Curr Drug Metab; 2013 Dec; 14(10):1070-82. PubMed ID: 24329113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin in cancer treatment and prevention.
    Morales DR; Morris AD
    Annu Rev Med; 2015; 66():17-29. PubMed ID: 25386929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetics of Antidiabetic Drugs.
    Srinivasan S; Yee SW; Giacomini KM
    Adv Pharmacol; 2018; 83():361-389. PubMed ID: 29801583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stratified medicine for the use of antidiabetic medication in treatment of type II diabetes and cancer: where do we go from here?
    Emami-Riedmaier A; Schaeffeler E; Nies AT; Mörike K; Schwab M
    J Intern Med; 2015 Feb; 277(2):235-247. PubMed ID: 25418285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using EHR-Linked Biobank Data to Study Metformin Pharmacogenomics.
    Breitenstein MK; Simon G; Ryu E; Armasu SM; Weinshilboum RM; Wang L; Pathak J
    Stud Health Technol Inform; 2015; 210():914-8. PubMed ID: 25991289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetics and personalized treatment of type 2 diabetes.
    Semiz S; Dujic T; Causevic A
    Biochem Med (Zagreb); 2013; 23(2):154-71. PubMed ID: 23894862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.